Main > PNEUMOLOGY > Asthma>Eosinophilic>Severe ** > Treatment > Co: IL. T. ReslizuMAb Injection

---

Co: IL. T. ReslizuMAb Injection's subsections
(*) EU Approval Date: 2016. 08.18
(*) USA Approval Date: 2016. 03.23
Company
Mechanism> IL-5 Inhibition
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2016. 09.20
TradeMark (EU)
TradeMark (USA)
TradeMark (USA) Web-Site

Co: IL. T. ReslizuMAb Injection's products
This section has no products